clinical

NIAID Integrated Research Facility (NEW YORK) — The first phase of human trials studying a possible nasal COVID-19 vaccine has opened, the National Institutes of Health (NIH) announced. The clinical trial, sponsored by the federal health agency, is enrolling participants at three sites across the U.S. Researchers believe the vaccine candidate may provide even better […]